NCT06616376

Brief Summary

This study was conducted to determine the effect of anti-embolism stocking (AES) use protocol affected the development of early venous thromboembolism (VTE) in patients undergoing total knee arthroplasty (TKA). The randomized controlled single-blind intervention study included 40 patients (Experimental Group: 20, Control Group: 20) who underwent TKA surgery in a university hospital's Orthopedics and Traumatology clinic between 2019 and 2021. While the experimental group received the AES protocol one day before the operation and continued until the 10 th day after the operation, the control group received AES on the 0 th day after the operation and remained in the patient until the 21st day after the operation. In the study, a "Data Collection Form" with DVT and PE signs and symptoms was used.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 16, 2019

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 17, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 17, 2021

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

November 16, 2022

Completed
1.9 years until next milestone

First Posted

Study publicly available on registry

September 27, 2024

Completed
Last Updated

September 27, 2024

Status Verified

September 1, 2024

Enrollment Period

1.3 years

First QC Date

November 16, 2022

Last Update Submit

September 24, 2024

Conditions

Keywords

Anti-embolism StockingsKnee ArthroplastyNonpharmacological MethodOrthopedic NursingVenous Thromboembolism

Outcome Measures

Primary Outcomes (2)

  • Distribution of Descriptive Characteristics and Surgical Information of the Patients

    The mean age of the experimental group was 68.6±7.1 years (range: 51-81 years) and the mean age of the control group was 68.5±8.8 years (range: 57-89 years). There was chronic disease in 90% of the experimental group, and the rate of chronic disease in the control group was 60%. Mobility status of the experimental group 1 day before the surgery; 65% (n:13) were independent, 15% (n:3) self-supported and 20% (n:4) needed help. Mobility status of the control group 1 day before the surgery; 60% (n:11) were independent, 40% (n:8) self-supported, and 5% (n:1) needed help. Mobility status of the experimental group after surgery; 10% (n:2) were independent, 90% (n:18) were self-sufficient. Mobility status in the control group; 20% (n:4) were independent, 75% (n:15) were self-sufficient and 5% (n:1) needed help. All patients in the experimental and control groups used low molecular weight heparin or anticoagulants before surgery.

    Three weeks

  • VTE Evaluation Form

    It consists of 19 questions covering symptoms of VTE, DVT and PE.

    Three weeks

Secondary Outcomes (1)

  • The Use of Anti Embolism Stocking Protocol

    Two weeks

Study Arms (2)

Experimental Group

EXPERIMENTAL

AES was redressed within the 21st day after the operation

Other: Anti-Embolism Stocking

Control Group

NO INTERVENTION

The AES was dressed within the 10st day after the operation remained in the patient until the sutures

Interventions

To prevent patients undergoing TKA surgery from being affected by one another, the patients were hospitalized in separate rooms, and the orthopedic clinic team was made aware of the situation. The patients in the control group were told not to remove their socks until the sutures were removed after the operation, whereas the patients in the experimental group were told to remove their socks on the 10th day after the operation, so the patients had no idea which group they were in.

Experimental Group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Older than 18 years old,
  • No harm in wearing AES,
  • Patients who agreed to participate in the study.

You may not qualify if:

  • Bilateral TKA used patients,
  • Having excess leg edema, pulmonary edema, heart failure,
  • Having leg ischemia,
  • Having skin graft,
  • An open wound in the area where AES will be applied,
  • Having arterial and venous vessel disease,
  • Having neuropathy,
  • Having cellulite on the patient's leg to whom AES will be applied,
  • Having an infection such as fasciitis or panniculitis,
  • Those who declare that they will not use AES for ten days in accordance with the recommendations.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cukuruvo University

Adana, Sarıcam/Adana, 01330, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Venous Thromboembolism

Condition Hierarchy (Ancestors)

ThromboembolismEmbolism and ThrombosisVascular DiseasesCardiovascular Diseases

Study Officials

  • Sevilay ERDEN, Assoc.Prof.

    Ç.Ü Faculty of Health Sciences Department of Surgical Nursing

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
To prevent patients undergoing TKA surgery from being affected by one another, the patients were hospitalized in separate rooms, and the orthopedic clinic team was made aware of the situation. The patients in the control group were told not to remove their socks until the sutures were removed after the operation, whereas the patients in the experimental group were told to remove their socks on the 10th day after the operation, so the patients had no idea which group they were in.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: The study was conducted as a randomized controlled single-blind intervention study to determine the effect of the AES use protocol on the development of early VTE in patients undergoing knee arthroplasty.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
specialist nurse

Study Record Dates

First Submitted

November 16, 2022

First Posted

September 27, 2024

Study Start

October 16, 2019

Primary Completion

February 17, 2021

Study Completion

February 17, 2021

Last Updated

September 27, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations